40+ results for "IoT"
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
REYKJAVIK, ICELAND (August 21, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic licensing and commercialization agreement with Lotus Pharmaceutical (TWSE Stock Code: 1795) covering two of Alvotech’s candidates in the United States and selected Asian markets: AVT34, a proposed biosimilar to Imfinzi® (durvalumab), and AVT87, a proposed biosimilar to H
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed U.S. patients annually and no currently FDA-approved therapy Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing, with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations received and alignment with FDA that a single successful pivotal trial could potential
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed U.S. patients annually and no currently FDA-approved therapy Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing, with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations received and alignment with FDA that a single successful pivotal trial could potential
Elliott Management Statement on Northern Star Resources Ltd
WEST PALM BEACH, Fla. , Aug. 13, 2026 -- Elliott Investment Management L.P. ( Elliott ), which manages funds that together hold an investment of approximately 5.6% in Northern Star Resources Ltd ( Northern Star or the Company ), today issued the following statement in response to the Company s announcements on August 13: Northern Star s August 13 letter asks investors to trust the very directors who presided over years of profound underperformance to oversee a Board renewal process on terms they alone control, consisting of directors appointed solely at their discretion. This is not renewal. It is entrenchment.
Elliott Management Sends Letter to Northern Star Resources Ltd Board of Directors
Reiterates Need for Substantial Board Enhancement, Comprehensive Strategic Review and Credible Operational Plan Introduces Group of Highly Accomplished Independent Director Candidates for Northern Star Board Full Letter and Materials Available at ElliottLetters.com/NST WEST PALM BEACH, Fla. , Aug. 12, 2026 -- Elliott Investment Management L.P. ( Elliott ), which manages funds that together hold an investment of approximately 5.6% in Northern Star Resources Ltd ( Northern Star or the Company ), today sent a letter to the Company s Board of Directors.
Chandigarh University Students' 'Green Heart' Wins NASSCOM's Best Startup Award, Bags ₹5 Lakh Grant to Transform Farming with AI, Satellites & IoT
From Campus Innovation to AgriTech Breakthrough: Chandigarh University Students Green Heart Wins NASSCOM s Best Startup Award CHANDIGARH, India , Aug. 11, 2026 -- A Chandigarh University student startup has secured the Best Startup Award, along with a Rs 5,00,000 grant for its Al-driven smart agriculture technology platform GreenHeart at Neovation 2026 (ThingQbator), a prestigious innovation and startup incubation initiative organized by NASSCOM, the apex body representing India s 250-billion technology sector.
SABESP Partners with Vivo and IDEMIA Secure Transactions, to Power the World's Largest IoT Initiative for a Secure and More Sustainable Water Management in Brazil
SABESP, the water and sanitation company of the State of S o Paulo, Brazil, announces the deployment of the world s largest Internet of Things (IoT) connectivity project for smart water management. The initiative is being implemented in partnership with Telefonica/Vivo, a key player in Brazil s technological transformation and one of the largest mobile operators in the continent, and IDEMIA Secure Transactions (IST), a global leader in payment and connectivity solutions, marking a significant milestone in the country s digital and environmental transformation.
Manipal Hospital, Bengaluru Installs India's First Elekta Evo, Advancing AI-Enabled Adaptive Radiotherapy in India
BENGALURU, India , July 31, 2026 -- In a significant advancement for cancer care in India, Manipal Hospital, Yelahanka, Bengaluru has become the first healthcare institution in the country to install Elekta Evo, the company s AI-enhanced adaptive CT-Linac platform. The installation enables clinicians to deliver Online Adaptive Radiotherapy (ART), supporting more personalised and precision-led radiation therapy for patients.
Elevated Materials Strengthens Commercial Leadership with Appointment of Jay Wang as Chief Revenue Officer
Jay Wang brings global commercial leadership across semiconductors, LEDs, and advanced battery markets as Elevated Materials expands customer adoption of its ultra-thin lithium films. SANTA CLARA, Calif. , July 30, 2026 -- Elevated Materials, a leading manufacturer of ultra-thin lithium films for next-generation batteries, today announced the appointment of Jay Wang as Chief Revenue Officer. Jay brings more than two decades of global sales, business development, and general management experience across battery, semiconductors, LEDs, and advanced technology markets. He has led commercial organizations across Asia and the United States, building high-performing teams, expanding customer relationships, and driving revenue growth across automotive, consumer electronics, AI, networking, IoT, and industrial markets.
Chandigarh University's Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies
Leading national & global companies like Sun Pharma, GSK, Medtronic India, Serum Institute of India recruit Chandigarh University students CHANDIGARH, India , July 30, 2026 -- The rapid growth of Biotechnology, Pharmaceutical Sciences and allied healthcare fields has triggered a high demand for professionals equipped with specialized knowledge, practical skills and industry exposure. To meet this growing demand, Chandigarh University has integrated experiential learning model into its Biotechnology and Pharmaceutical Sciences programmes with 178 students securing placements and 261 students gaining industry internships in leading pharmaceutical companies, reputed healthcare institutions (hospitals) and life sciences organisations over the past three years.
Iridium and SKYWAVE™, an ORBCOMM® company, Partner to Advance Global Industrial IoT for Heavy Equipment OEMs
Partnership combines SKYWAVE s intelligent network orchestration solution with Iridium s pole-to-pole LEO satellite network to help equipment manufacturers modernize connected operations and extend connectivity worldwide. MCLEAN, Va. , July 28, 2026 -- Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice, data, aircraft surveillance, and positioning, navigation, and timing (PNT) satellite services, today announced a strategic partnership with SKYWAVE , a global leader in industrial IoT connectivity, devices and enablement solutions for mission-critical assets, to help heavy equipment manufacturers build and scale more resilient connected equipment services across global operating environments.
Seaweed extract shown to relieve prostate symptoms
In a breakthrough clinical trial undertaken by Australian biotechnology company Marinova, a unique seaweed extract has been shown to relieve the symptoms of benign prostatic hyperplasia (BPH). HOBART, Australia , July 27, 2026 -- A randomised, double-blind, placebo-controlled clinical trial evaluated the effects of fucoidan, a naturally occurring compound found in brown seaweed, on men with BPH (prostate enlargement). BPH is a common health issue for men across the globe. Worldwide estimates place prevalence at 50-60% of men in their 60s, increasing to 90% of men in their 80s. While it is typically not life-threatening, urinary symptoms including difficulty passing urine, a weak stream and an increase in the frequency of urination often result in a significant reduction in quality-of-life.
Chandigarh University's 272 Allied Health Sciences Students Secure Jobs in Prestigious Govt & Private Hospitals in Past 3 Years
University Boosts Employability with Internships for 393 Allied Health Sciences Students at Top Health Institutions CHANDIGARH, India , July 25, 2026 -- Chandigarh: Chandigarh University (CU) students of Allied Health Sciences -- Optometry, Forensic Science, Medical Laboratory Science, Nutrition and Dietetics and Physiotherapy - have secured over 272 jobs in leading corporate organisations and prestigious government and private healthcare institutions including AIIMS Rishikesh, PGIMER Chandigarh, Fortis Hospital, Max Super Specialty Hospital and government-run Forensic Science Laboratories during the past three years, reflecting CU s world-class education, industry-oriented curriculum, hands-on clinical training and robust placement ecosystem that prepares students for successful careers in healthcare.
CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
CancerFax is strengthening its end-to-end patient navigation support for Indian and international patients exploring advanced oncology treatment options at leading hospitals in China, with an emphasis on hospital-based medical evaluation and responsible access. NEW DELHI , July 13, 2026 -- As China continues to gain attention for advanced oncology treatments including cancer gene therapy, CAR-T cell therapy, immunotherapy, advanced radiotherapy, and clinical trial programs, CancerFax has strengthened its India China patient navigation pathway to help eligible patients and families explore these options through responsible medical evaluation and hospital coordination.
Elliott Management Statement on Northern Star Resources Ltd
WEST PALM BEACH, Fla. , July 2, 2026 -- Elliott Investment Management L.P. ( Elliott ), which manages funds that together hold an investment of well over A 1 billion in Northern Star Resources Ltd ( Northern Star or the Company ), today issued the following statement in response to the Company s announcements on July 2: Elliott notes Northern Star s announcements and remains committed to seeing the Company realize its full potential. The need for substantial board enhancement and a comprehensive strategic review has not diminished, and we look forward to engaging with Northern Star s new leadership on these topics and delivering the value that shareholders deserve.
Basecamp Research brings EDEN's antibiotic and vaccine design models to Claude Science
Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks to integration with Basecamp Research s EDEN models. LONDON and CAMBRIDGE, Mass. , June 30, 2026 -- Basecamp Research today announced that its antibiotic design and vaccine target prediction EDEN models are now available through Claude , including Claude Science, Anthropic s AI workbench for life sciences research. This allows researchers to generate and prioritise therapeutic candidates through a conversational interface in a matter of minutes.
NYSE Content Update: Doncasters Shares Jump 42% in NYSE Trading Debut
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 26, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. JD Durkin delivers the pre-market update on June 26thShares of UK manufacturer Doncasters (NYSE: DPC) rose sharply in the first day of trade following its IPO, as investors remain bullish on aerospace and defense.U.S. Bank (NYSE: USB) released its latest Small Business Perspective, revealing that Gen Z business owners are more active in pursuing growth opportunities.The Society for Immunotherapy of Cancer will be hosting a meeting at the NYSE to discuss new strategies in combating cancer.President Dr. James Gulley and SITC Biotech Committee Founding Chair Dr. Zhen Su will join NYSE Live to discuss how the organization.The NYSE is on the ground at today's Uncharted Summit in Southampton, an event bringing together an exclusive group of investors and founders.
Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
More than 450 executives from 100+ leading life sciences organizations gathered in Princeton, NJ to move agentic AI past the proof-of-concept stageFounder and CEO Jaswinder "Jassi" Chadha challenged the industry with a counterintuitive mandate: before you build more agents, fix the foundation firstThe Ignite Leadership Awards honored transformation leaders from Bristol Myers Squibb, GSK, and Biogen; the Axtria Bedrock Honor recognized a 15-year partnership with Quest DiagnosticsBERKELEY HEIGHTS, N.J., June 25, 2026 -- Axtria Inc., a global leader in AI-first data & analytics solutions and platforms for the life sciences industry, hosted Axtria Ignite 2026 on June 10 and 11 at the Princeton Marriott at Forrestal under the theme "Industrializing Intelligence: The Agentic Enterprise." More than 450 executives from over 100 leading life sciences, MedTech, and biotech organizations gathered to work through the harder question of 2026: what must be true before an enterprise can trust AI to run at machine speed.
Dahua Technology Showcases "Visible AI in New Energy" at Intersolar Europe 2026
MUNICH, June 25, 2026 -- Dahua Technology, a world-leading video-centric AIoT solution and service provider, showcased its latest innovations for the renewable energy industry at Intersolar Europe 2026. Under the theme "Visible AI in New Energy," Dahua demonstrated how AIoT technologies can help energy operators enhance efficiency, reliability, and security across the entire energy value chain, from power generation and transmission to consumption. At this year's exhibition, Dahua presented a comprehensive portfolio of solutions covering five key application areas: Intelligent Security, Equipment Inspection, HSE-PPE Management, EV Charging, and Smart Control Centre. Together, these solutions address the growing need for smarter operations, safer workplaces, and more efficient asset management across renewable energy infrastructure.
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan, June 24, 2026 -- REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds exclusive commercialization rights in Japan. The application seeks approval for the use of Stemchymal® to suppress the progression of ataxia in patients with spinocerebellar ataxia (SCA3 and SCA6). Under the established framework, Stemchymal® will be manufactured by Taiwan-based Steminent Biotherapeutics Inc., with REPROCELL overseeing all sales and distribution activities within Japan.
Iridium NTN Direct Begins Live Testing with Mlink
Mlink chipsets expand the ecosystem for Iridium's standards-based NB-IoT and D2D connectivity MCLEAN, Va., June 24, 2026 -- Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice, data, and positioning, navigation, and timing (PNT) satellite services, today announced that Mlink Technology Inc. (Mlink), a leading fabless semiconductor company specializing in IoT and satellite communication chipsets, has begun live, on-air testing of its MS150-IR IoT-NTN chipset using Iridium NTN Direct℠. MS150-IR is a specialized version of the MS150 chipset family, developed specifically for Iridium NTN Direct as part of Mlink's global IoT-NTN product portfolio.
Geri Care launches Coimbatore's first geriatrician-led Skilled Nursing Facility & Long-term Care Hospital for Senior Citizens
100-bed facility designed exclusively for the healthcare needs of older adultsBrings post-hospitalization and post-surgery care, rehabilitation, assisted living, dementia care and palliative care under one continuumCOIMBATORE, India, June 17, 2026 -- Geri Care, India's pioneer in integrated eldercare, today launched Coimbatore's first geriatrician-led Skilled Nursing Facility (SNF) and Long-term Care Hospital dedicated exclusively to senior citizens. Located centrally at Lakshmi Mills Junction, opposite Lulu Mall, the 100-bed facility has been purpose-built to address the evolving healthcare needs of older adults. The centre will also operate as a Geriatric Multispecialty Outpatient Clinic for Senior Citizens, equipped with ECG, Echo, Ultrasound, Pharmacy, Labs, Vaccinations, Physiotherapy and Rehabilitation for the community.
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 5, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on June 5thInvestors are reacting to the May jobs report after the DOW climbed to a record close on Thursday.AstraZeneca (NYSE: AZN) is celebrating its February transfer to the NYSE, the largest transfer by market capitalization in the NYSE's 234-year history.NYSE Live will provide exclusive coverage of CEO Pascal Soriot's remarks.CFO Dr. Aradhana Sarin will discuss the company's financial goals for 2030 in a live interview.Shares of Sunshine Silver Mining & Refining (NYSE: SSMR) jumped by 27% in its NYSE trading debut on Thursday.Stablecoin fintech RedotPay unveiled its first dedicated B2B product, RedotPay Connect, at Money20/20 Europe, which it says will reduce fees by 70% for global merchants.
RPX Corporation Announces Leadership Transition
Ryan Elliott to Succeed Dan McCurdy as Chief Executive Officer, Effective July 1SAN FRANCISCO, May 28, 2026 -- RPX Corporation, a leading patent risk management service provider, today announced that Ryan Elliott, industry veteran and Executive Vice President of Syndicated Acquisitions, has been appointed to the role of Chief Executive Officer, effective July 1, 2026. Mr. Elliott succeeds Dan McCurdy, who has served as RPX's CEO for the last eight years. "Serving as CEO of RPX has been a true privilege, and I am proud of all that our team has accomplished since 2018," said Mr. McCurdy. "After spending nearly a decade at RPX, I believe now is the right time to begin the transition to RPX's next generation of leadership. I am delighted to hand the reins to an executive of Ryan's caliber, and he is the right person to guide the Company through this next chapter of growth and value creation for RPX's nearly 350 members and Empower subscribers worldwide. Ryan has over a decade of leadership experience in IP law and patent risk solutions, and brings a deep understanding of our business, our members and their needs. I know Ryan will continue to foster a culture focused on our members, innovation, execution and excellence as he takes on the role of CEO."
Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing
NORWALK, Conn., May 18, 2026 -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' $4.75 million seed extension financing, with participation from Dementia Discovery Fund, UTEC, Ono Venture Investment, and Mass General Brigham Ventures. Violet Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies for neurodegenerative disease by mapping disease-relevant cell-to-cell signaling interactions in the brain. The company's proprietary CONNECT platform is designed to identify therapeutically actionable signaling pathways that drive neuroinflammation, neurodegeneration, and synaptic loss.
Haier Named the World's Only IoT Ecosystem Brand in Kantar BrandZ Top 100 for Eight Consecutive Years
QINGDAO, China, May 18, 2026 -- Kantar, a global leader in brand data and strategy consulting, recently released its BrandZ 2026 Top 100 Most Valuable Global Brands ranking. In the ranking, Haier Group has been named the world's only IoT ecosystem brand for eight consecutive years, with its position rising to 53rd place. The ranking evaluates not only financial performance but also places significant emphasis on a brand's equity strength and future growth potential in consumers' minds. Despite economic volatility, the total value of the world's top 100 brands rose 22% year-on-year to USD 13.1 trillion in 2026. Thirteen Chinese brands made it onto the list, while global tech giants Google, Apple, Microsoft and Amazon still take the lead. This year, Chinese brands delivered particularly strong results, posting an average year-on-year brand value increase of 32%.
Chandigarh University Biotechnology Scientists Faculty Secure Rs 1.16 Crore Government Grants from ICMR and ANRF for Mustard Yield and Diabetic Kidney Disease Research
Chandigarh University Scientist to Boost Mustard Productivity through Microbe-Based Research with Rs 60 Lakh PM-ECRG Grant from Anusandhan National Research Foundation; Reduce Dependence on Fertilizers, Give Fillip to Oilseed ProductionICMR Grants Rs 56 Lakh for Study led by Chandigarh University Researchers on Early Detection of Diabetic Kidney DiseaseCHANDIGARH, India, May 18, 2026 -- The research scientists faculty and students working in the biotechnology domain under University Centre for Research & Development (UCRD) at Chandigarh University have been making significant strides in the cutting-edge scientific research in areas such as agricultural biotechnology and plant molecular science and healthcare.
SUNMI Technology (06810.HK) Officially Listed on the Main Board of HKEX
HONG KONG, May 7, 2026 -- On April 29, 2026, SUNMI Technology Group Co., Ltd., a global leader in Business IoT (BIoT), was officially listed on the Main Board of the Hong Kong Stock Exchange under stock code 06810.HK, becoming the world's first publicly listed company in the Business IoT sector. Inside the trading hall of the Hong Kong Stock Exchange, founder, chairman, and CEO Jack Lin, together with the core management team, rang the ceremonial listing gong, marking the official entry of SUNMI Technology into the international capital market.
Hikvision releases 2025 ESG Report, advancing sustainability through 'Tech for Good'
HANGZHOU, China, April 28, 2026 -- Hikvision has released its 2025 Environmental, Social and Governance Report, marking the eighth consecutive year of transparent sustainability reporting. Guided by its THRIVE sustainability philosophy, the report refined its double materiality assessment, identifying technological innovation, product safety and quality, and cybersecurity as double materiality topics, advancing its sustainable development goals in a systematic manner.Advancing Social Good through AIoT
Dahua Technology Releases 2025 ESG Report: Advancing Sustainable Development Through Digital Intelligence
HANGZHOU, China, April 28, 2026 -- Dahua Technology, a world-leading video-centric AIoT solution and service provider, has released its seventh Environmental, Social and Governance (ESG) Report, outlining its ongoing efforts in sustainable development under its mission of "enabling a smarter society and better living." In 2025, Dahua further integrated ESG strategies into its global operations, focusing on green development, compliance, and responsible use of technology. The company was awarded a Silver Medal by EcoVadis, ranking among the top 15% of companies worldwide.
Shanghai Electric Highlights AI-Driven Integration of Energy and Industry at Hannover Messe 2026
HANNOVER, Germany, April 24, 2026 -- Shanghai Electric (SEHK: 02727, SSE: 601727), a global leader in providing integrated solutions for the energy and industrial sectors, is exhibiting at Hannover Messe 2026 under the theme of "Interlocking Energy and Industry," showcasing its green energy products, integrated energy solutions, and AI-enabled industrial application scenarios. Against the backdrop of Europe's energy transition and the rising demand for AI adoption in manufacturing, Shanghai Electric aims to explore more opportunities for in-depth cooperation. It features four exhibition zones at Hannover Messe 2026: "AI for Industry," "Zero-Carbon Parks," "POWER to X," and "IIoT Digital Foundation," showcasing multi-scenario solutions and real-world international project deployments that demonstrate Shanghai Electric's integrated strength in driving synergistic industrial chain development across its two core sectors of energy and industry.
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
PISCATAWAY, N.J., April 22, 2026 -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the Entrepreneur Of The Year® 2026 New Jersey Award by Ernst & Young LLP. The Entrepreneur Of The Year program is one of the world's most prestigious business awards for entrepreneurs and transformational leaders. For more than four decades, the program has recognized visionary leaders who build and sustain successful businesses through innovation, growth, resilience, and long-term impact.
AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have been selected for poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The data demonstrate ABT-301's superior performance in enhancing immunotherapy for colorectal cancer (CRC) and reveal a novel mechanism for overcoming chemotherapy resistance in pancreatic cancer.
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030.PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 -- GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, today announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves data in the age of Artificial Intelligence.
Rapidise: Powering India's Next-Generation Electronics Manufacturing Revolution
AHMEDABAD, India and NEW DELHI, April 9, 2026 -- Rapidise, a leading ODM and EMS provider, is driving India's growth in intelligent hardware products. As the electronics manufacturing sector expands, the company is strengthening its capabilities to meet rising demand for Vision Edge AI devices, IoT products, and high-precision electronics. Supported by state-of-the-art facilities and advanced technologies, Rapidise focuses on manufacturing solutions for Vision AI products, smart cameras, edge devices and connected hardware platforms, enabling hardware companies to scale faster and bring products to market more cost-efficiently.
Cisco Report: Strategic Wireless Investments are Driving Higher ROI for Enterprises in the AI Era
News summary:Wi-Fi Investment Momentum: Driven by the rise of AI, IoT, and high-bandwidth applications, four out of five organizations increased wireless investment in the past five years, with a similar number forecasting continued budget increases.The Multiplier Effect: Strategic wireless investment drives business value, with more than two-thirds of organizations reporting positive revenue impacts, and three quarters experiencing enhanced customer engagements and seeing efficiency gains.The Wireless AI Paradox: Organizations that can successfully navigate challenges posed by AI (complexity, security and talent) are reaping the rewards with greater wireless ROI.The Automation Imperative: AI-driven operations can help reclaim 850+ hours per IT practitioner annually, shifting teams from reactive "ticket cycles" to high-value strategic initiatives.
NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 1, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on April 1stStocks aim to add to gains Wednesday morning as the S&P 500 rallied 2.9% yesterday for its best session since May.Versigent (NYSE: VGNT) CEO Joseph Liotine will join NYSE Live this morning as its shares debut for trade following its spinoff from Aptiv (NYSE: APTV).TD Synnex (NYSE: SNX) CFO David Jordan will join NYSE Live to explain the IT distributor's better-than-expected first quarter financial results.Find Public.com Co-CEO Jannick Malling on Taking Stock talking about its AI agents for investor portfolios.
Elliott Management Statement on Mitsui O.S.K. Lines, Ltd.
LONDON, April 1, 2026 -- Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together have a significant investment in Mitsui O.S.K. Lines, Ltd. ("Mitsui O.S.K." or the "Company"), today issued the following statement: Elliott notes the initiatives outlined in Mitsui O.S.K.'s new Medium-Term Management Plan ("MTMP") as positive steps toward improving shareholder returns and increasing capital efficiency. However, Elliott remains concerned that the MTMP does not go far enough in closing Mitsui O.S.K.'s significant gap in shareholder returns to its peers or concretely addressing the large unrealized gains from vessels and real estate on the Company's balance sheet. Mitsui O.S.K. must more ambitiously confront the factors behind its deep undervaluation. Elliott is committed to working constructively with the Company on the steps needed to achieve its stated goal of trading at a premium to book value.
Infineon partners with Zenergize to enable India-designed power-electronics for the country's energy transition
– Infineon's advanced wide-bandgap semiconductors and microcontroller platforms to support Zenergize in building cutting-edge solar inverters, EV fast chargers, and energy-storage systems– Partnership advances India's path to technology self-reliance by enabling domestic design and manufacturing of high-performance power-electronics- Picture is available at AP -NEW DELHI, March 19, 2026 -- Infineon Technologies AG (FSE: IFX) (OTCQX: IFNNY), a global leader in semiconductor solutions for power systems and IoT, today announced a strategic technology partnership with Zenergize, an emerging Indian power-electronics company designing and manufacturing high-performance solutions for the solar, EV charging, and clean-energy sectors. This announcement was made at Bharat Electricity Summit (BES) 2026 at Yashobhoomi, New Delhi.
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion.DELFT, Netherlands, March 12, 2026 -- GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and reinforcing Europe as a core pillar of its integrated R&D and production network. The Delft facility strengthens GenScript's transatlantic biotechnology infrastructure, enabling greater regional proximity, regulatory alignment, and supply chain resilience for European innovators developing next-generation therapies, vaccines, and advanced biologics.